Signaling Pathways - Farnesoid X receptors (FXRs) - CSF1R - PD-1/PD-L1 interaction - 5-HT3 Receptors
清除全部
- B6023 PD-1/PD-L1 inhibitor 2Target: PD-1/PD-L1 interactionSummary: PD-1/PD-L1相互作用的抑制剂
- B5854 Pexidartinib (PLX3397)3 Citation中文名: 培西达替尼Target: FLT3|c-Kit|CSF1RSummary: CSF-1R抑制剂
- B4888 Obeticholic Acid2 Citation中文名: 奥贝胆酸Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂
- B2241 Ondansetron中文名: 昂丹司琼Target: 5-HT3 ReceptorsSummary: 血清素5-HT3受体拮抗剂
- B2259 VUF 10166Target: 5-HT3 ReceptorsSummary: 5-HT3受体拮抗剂
- B2258 Tropisetron Hydrochloride中文名: 盐酸托烷司琼Target: 5-HT3 ReceptorsSummary: 5-HT3受体拮抗剂
- B1528 XL335Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂
- A8463 Lithocholic Acid中文名: 石胆酸Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)Summary: 维生素D受体PXR和FXR的激活剂
- A5166 Ondansetron HCl中文名: 盐酸昂丹司琼Target: 5-HT3 ReceptorsSummary: 5-HT3受体拮抗剂
- A1334 Mosapride Citrate中文名: 莫沙必利柠檬酸盐Target: 5-HT3 Receptors|5-HT4 ReceptorsSummary: 5-HT受体激动剂